Molecular Breast Imaging Of Ohio is categorized under Health Screening Services in Columbus, OH and active since 2011.
Molecular Breast Imaging Of Ohio was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Screening Services business, which does work in the B2C market, and is classified as a Health Screening Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact John Olsen at the company’s single location by writing to 4645 Stonehaven Drive, Columbus, Ohio OH 43220 or by phoning (614) 459-0239. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Molecular Breast Imaging Of Ohio |
| Contact Person: | John Olsen |
| Address: | 4645 Stonehaven Drive, Columbus, Ohio 43220 |
| Phone Number: | (614) 459-0239 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Screening Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Molecular Breast Imaging Of Ohio was started in 2011 to provide professional Health Screening Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact John Olsen for inquiries that concern Molecular Breast Imaging Of Ohio by calling the company number (614) 459-0239, as your correspondence is most welcome. Additionally, the physical location of the single location of Molecular Breast Imaging Of Ohio can be found at the coordinates 40.049176,-83.086076 as well as the street address 4645 Stonehaven Drive in Columbus, Ohio 43220.
For its online presence, you may visit Molecular Breast Imaging Of Ohio’s website at and engage with its social media outlets through on Twitter and on Facebook.